September 24, 2012

During this paramount election year, the National Association of Chain Drug Stores’ grassroots advocacy program — NACDS RxImpact — continues to demonstrate the importance of pharmacy advocates engaging on behalf of community pharmacy, NACDS has announced.

September 21, 2012

Giant Food is bringing back its A+ School Rewards program.

August 30, 2012

As of Sept. 1, some 1.2 million Pennsylvanians will be able to go to bed at night secure in the knowledge that their jobs won't be drowned out by some online juggernaut. And by the middle of September, 3.1 million Californians will be able to breathe that same sigh of relief.

August 30, 2012

ScripsAmerica last week announced that the company has secured $1 million in financing which it will use to develop, manufacture and distribute its RapiMed brand of children's pain reliever and other core business products.

August 3, 2012

Harris Teeter plans to expand its presence in existing markets, the company said in its third-quarter earnings release.

July 27, 2012

A survey released by Chase Slate with Blueprint revealed that more back-to-school shoppers are carefully managing their spending and borrowing by creating a budget and sticking to it.

July 24, 2012

A district court ruled in favor of Pfizer and Northwestern University in a patent infringement case relating to Lyrica (pregabalin).

June 19, 2012

The U.S. Court of Appeals for the Federal Circuit ruled in favor of Watson Pharmaceuticals during patent litigation concerning the drug maker's abbreviated new drug application for an overactive bladder treatment.

April 19, 2012

Generic drug maker Watson is challenging the patent protection on a drug used to treat Type 2 diabetes.

April 12, 2012

AstraZeneca has launched a new drug for treating high blood pressure, the company said Thursday.

April 4, 2012

A court has ruled that patents covering a drug used for overactive bladder are invalid, a company looking to launch a generic version of the drug said.

February 16, 2012

Marley Coffee has inked a distribution agreement that will expands its line's availability on the East Coast, as well as in Hawaii.

February 14, 2012

Generic drug maker Mylan plans to challenge a court decision that requires it to pay almost $20 million to a drug company whose product it tried to market as a generic.

December 13, 2011

Unilever’s Dove Hair has announced the real woman star of its new “Make Friends with Your Hair” television ad campaign.

November 15, 2011

The generic drug lobby is stepping up its efforts to persuade the congressional super committee to avoid adopting rules that would ban some patent settlements between branded and generic drug makers.

October 19, 2011

The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO’s drugs by the end of the decade.

October 4, 2011

The Medicines Co. and generic drug maker Teva Pharmaceutical Industries have reached a settlement that will allow Teva to start selling a generic version of one of MDCO's drugs by the end of the decade.

September 30, 2011

A fifth dietary supplement trade association may be in the early formulation stages, specifically designed to address the Food and Drug Administration's recent issues of New Dietary Ingredient guidance, according to a Nutrition Business Journal report published Wednesday.

September 13, 2011

Impax Labs has hit a roadblock in its attempt to market a generic version of a symptomatic benign prostatic hyperplasia drug.

September 1, 2011

Pfizer and Dr. Reddy's have reached a settlement over the latter's efforts to launch a generic version of the world's top-selling drug, according to published reports.

August 30, 2011

Mylan will be banned temporarily from launching a generic drug for acne pending a federal court's decision whether or not to bar it, according to published reports.

August 22, 2011

A new drug made by AstraZeneca is available in pharmacies following its regulatory approval in July, the company said Monday.

July 21, 2011

The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

July 20, 2011

A Food and Drug Administration committee of experts has advised against approving a drug for Type 2 diabetes made by AstraZeneca and Bristol-Myers Squibb, the companies said Tuesday.